THE US National Cancer Institute plans to test nationwide a drug called taihoxifen that might prevent breast cancer, lower the number of deaths from heart attacks and reduce the number of broken bones among middle-aged and older women. The trial, over a period of five years, will involve about 16,000 women between the ages of 35 and 59, half of who will be given a 20-milligram dose of the drug and the others a placebo.
Tamoxifen has some side effects such as blood clotting and early opause, and uterine cancer in older women. The rug has also been linked to liver cancer in rats.
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/new-drug-cancer
[2] http://admin.indiaenvironmentportal.org.in/category/newspaper/down-earth
[3] http://admin.indiaenvironmentportal.org.in/category/thesaurus/ecology
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/agriculture
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/tropical-forests
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/diarrhoea
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health-care
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/technology